MarketCap
Facebook
X
TelegramQuartalsbericht 2025-Q4
hinzugefügt 14.01.2026
Land |
 Vereinigte Staaten |
IPO-Jahr |
- |
Branche |
Diagnostik & Forschung |
Börse |
NASDAQ CAPITAL |
Anteile |
2.3 M |
Marktkapitalisierung |
$ 6.18 M |
EBITDA (LTM) |
$ -4.66 M |
P/E (LTM) |
-2.14 |
P/S (LTM) |
1.1 |
EPS (LTM) |
-1.2 |
Andere Aktien der Branche "Diagnostik & Forschung"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
 |
Akumin
AKU
|
- | -17.87 % | $ 25.9 M | Nasdaq Capital Market |  Canada |
 |
Anixa Biosciences
ANIX
|
$ 3.11 | -2.51 % | $ 101 K | Nasdaq Capital Market | USA |
|
Centogene N.V.
CNTG
|
- | -6.23 % | $ 30.6 M | Nasdaq Global Market |  Germany |
 |
Accelerate Diagnostics
AXDX
|
- | -61.36 % | $ 2.46 M | Nasdaq Global Select Market | USA |
 |
Brainsway Ltd.
BWAY
|
$ 22.32 | -3.71 % | $ 99.4 M | Nasdaq Global Select Market |  Israel |
 |
BioNano Genomics
BNGO
|
$ 1.45 | -3.67 % | $ 1.84 M | Nasdaq Capital Market,SPB | USA |
 |
Aspira Women's Health
AWH
|
- | -6.19 % | $ 10.5 M | Nasdaq Capital Market,SPB | USA |
 |
Burning Rock Biotech Limited
BNR
|
$ 30.5 | -4.72 % | $ 328 M | Nasdaq Global Market |  China |
 |
Biocept
BIOC
|
- | -13.05 % | $ 7.29 M | Nasdaq Capital Market | USA |
 |
Check-Cap Ltd.
CHEK
|
- | - | $ 9.42 M | Nasdaq Capital Market | Israel |
 |
Castle Biosciences
CSTL
|
$ 40.78 | 1.92 % | $ 1.13 B | Nasdaq Global Market,SPB | USA |
 |
Co-Diagnostics
CODX
|
- | - | $ 79.8 M | Nasdaq Capital Market | USA |
 |
DexCom
DXCM
|
$ 70.44 | 1.29 % | $ 27.2 B | Nasdaq Global Select Market,SPB | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
- | - | $ 562 M | Nasdaq Global Select Market |  Britain |
 |
Chembio Diagnostics
CEMI
|
- | 0.22 % | $ 16.8 M | Nasdaq Capital Market | USA |
 |
Guardant Health
GH
|
$ 113.62 | 1.32 % | $ 13.9 B | Nasdaq Global Select Market,SPB | USA |
 |
Global Cord Blood Corporation
CO
|
- | - | $ 399 M | NYSE | China |
 |
Fluidigm Corporation
FLDM
|
- | 1.08 % | $ 308 M | Nasdaq Global Select Market | USA |
 |
Genetic Technologies Limited
GENE
|
- | - | $ 7.1 B | Nasdaq Capital Market |  Australia |
 |
Genetron Holdings Limited
GTH
|
- | 0.12 % | $ 80.1 M | Nasdaq Global Market | China |
 |
DermTech
DMTK
|
- | -11.32 % | $ 2.94 M | Nasdaq Capital Market,SPB | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
- | - | $ 10.7 B | Nasdaq Global Select Market | USA |
 |
Illumina
ILMN
|
$ 147.36 | 4.03 % | $ 23.4 B | Nasdaq Global Select Market,SPB | USA |
 |
CareDx, Inc
CDNA
|
$ 20.08 | 0.35 % | $ 1.08 B | Nasdaq Global Market,SPB | USA |
 |
Danaher Corporation
DHR
|
$ 234.95 | -0.44 % | $ 172 B | NYSE,SPB | USA |
 |
Celcuity
CELC
|
$ 105.63 | -1.25 % | $ 4.17 B | Nasdaq Global Select Market | USA |
 |
DarioHealth Corp.
DRIO
|
$ 12.48 | 0.28 % | $ 354 M | Nasdaq Capital Market | Israel |
 |
Enzo Biochem
ENZ
|
- | -8.98 % | $ 14.8 K | NYSE | USA |
 |
Fulgent Genetics
FLGT
|
$ 27.65 | -1.53 % | $ 836 M | Nasdaq Global Market | USA |
 |
HTG Molecular Diagnostics
HTGM
|
- | -20.0 % | $ 1.06 M | Nasdaq Capital Market | USA |
 |
Exact Sciences Corporation
EXAS
|
$ 102.21 | -0.22 % | $ 18.9 B | Nasdaq Capital Market,SPB | USA |
 |
Lantheus Holdings
LNTH
|
$ 66.02 | 2.75 % | $ 4.57 B | Nasdaq Global Select Market,SPB | USA |
 |
Medpace Holdings
MEDP
|
$ 602.32 | -1.41 % | $ 18.6 B | Nasdaq Global Select Market,SPB | USA |
 |
IQVIA Holdings
IQV
|
$ 234.18 | -1.47 % | $ 42.5 B | NYSE,SPB | USA |
 |
QIAGEN N.V.
QGEN
|
- | - | $ 10.6 B | NYSE |  Niderland |
 |
Heska Corporation
HSKA
|
- | - | $ 1.31 B | Nasdaq Capital Market,SPB | USA |
 |
Neogen Corporation
NEOG
|
$ 9.28 | 0.27 % | $ 2.01 B | Nasdaq Global Select Market,SPB | USA |
 |
National Research Corporation
NRC
|
$ 22.06 | -0.72 % | $ 541 M | Nasdaq Global Select Market | USA |
 |
Charles River Laboratories International
CRL
|
$ 219.04 | -0.3 % | $ 11.3 B | NYSE,SPB | USA |
 |
OPKO Health
OPK
|
$ 1.3 | 1.56 % | $ 902 M | Nasdaq Global Select Market | USA |
 |
Pacific Biosciences of California
PACB
|
$ 2.36 | 6.79 % | $ 599 M | Nasdaq Global Select Market,SPB | USA |
 |
Quest Diagnostics Incorporated
DGX
|
$ 188.87 | -0.33 % | $ 21 B | NYSE,SPB | USA |
|
Biodesix
BDSX
|
$ 8.85 | 12.25 % | $ 1.15 B | Nasdaq Global Market | USA |
 |
Mettler-Toledo International
MTD
|
$ 1 409.56 | -3.5 % | $ 29.9 B | NYSE,SPB |  Schweiz |
 |
Laboratory Corporation of America Holdings
LH
|
$ 272.02 | 0.42 % | $ 22.8 B | NYSE,SPB | USA |
 |
ICON Public Limited Company
ICLR
|
$ 176.57 | -3.31 % | $ 14.6 B | Nasdaq Global Select Market,SPB |  Irlanda |
 |
IDEXX Laboratories
IDXX
|
$ 688.67 | -3.73 % | $ 56.8 B | Nasdaq Global Select Market,SPB | USA |
 |
Myriad Genetics
MYGN
|
$ 5.65 | -4.56 % | $ 512 M | Nasdaq Global Select Market,SPB | USA |
 |
ENDRA Life Sciences
NDRA
|
$ 4.67 | -2.3 % | $ 2.51 M | Nasdaq Global Select Market | USA |
 |
Agilent Technologies
A
|
$ 135.52 | -2.95 % | $ 41.2 B | NYSE,SPB | USA |